The changes of platelet and platelet activation markers in acute coronary syndrome patients.
To investigate the changes of platelet microparticle (PMPs), monocyte-platelet aggregation (MPAs), and the platelet membrane glycoprotein GPIIb/IIIa ligands (PAC-1) and P-hormone (CD62P) activation ratio changes in acute coronary syndrome (ACS) patients. 92 patients were divided into ACS group (54 cases) and coronary angiography negative group (38 cases). 30 cases of age/gender matched healthy control group were recruited. The flow cytometry analysis in each group of PMPs, the MPAs expression of CD62P, GPIIb/IIIa activation ratio, and ROC curve were performed to evaluate the sensitivity and specificity of each parameter. The healthy control group showed MPAs 5.94 +/- 1.93%, PMPs 1.89 +/- 0.53%, and PAC-1 2.86 +/- 0.93%, the coronary angiography-negative group showed MPAs 11.97 +/- 4.92%, PMPs 3.08 +/- 1.38%, and PAC-1 3.38 +/- 0.92%, and the ACS group showed MPAs 46.27 +/- 17.74%, PMPs 5.28 +/- 2.44%, and PAC-1 5.34 +/- 2.44%. In the ACS group, the area under the ROC curve of each indicator for identifying suspected ACS patients were MPAs (0.952), PMPs (0.807), PAC-1 (0.770), and CD62p (0.656). MPAs showed the highest sensitivity (94.4%) and specificity (84.2%) for the diagnosis of ACS. acute coronary syndrome, platelet microparticle, monocyte-platelet aggregation, CD62P, GPIIb/IIIa.